Skip to content
value.today

Mercury Bio, Inc.

🇺🇸 Santa Fe, New Mexico, USABiotechnologyFounded 2020
Total raised
$5 M
3 rounds on record
Latest round
$2 M
Oct 2026
First round on record
Feb 2023
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Mercury Bio, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2026$2 MNo. 3Under $2 million

Mercury Bio, Inc.: Raise no. 3, Oct 2026

Investors in this round

3 investors had bought by the notice of Nov 13, 2026: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce McCormick · Executive Officer, Director
  • Alex Koglin · Director
  • Bryan Scheer · Director
  • Dana Barnard · Director
  • John Tomes · Director
  • Kevin McDonald · Director
  • Mike Rice · Director
  • Steve Kiziuk · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce McCormick, Ceo. Source: SEC Form D, newest notice filed Nov 13, 2026. Read the notice at the SEC.

equitySEC
Sep 2025$2 MNo. 2$2 to $10 million

Mercury Bio, Inc.: Raise no. 2, Sep 2025

Investors in this round

6 investors had bought by the notice of Oct 24, 2025: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $8 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce McCormick · Executive Officer, Director
  • Paul Laur · Executive Officer, Director
  • Alex Koglin · Director
  • Dana Barnard · Director
  • John Tomes · Director
  • Kevin McDonald · Director
  • Mike Rice · Director
  • Steve Kiziuk · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce McCormick, Ceo. Source: SEC Form D, newest notice filed Oct 24, 2025. Read the notice at the SEC.

equitySEC
Feb 2023$1 MNo. 1Under $2 million

Mercury Bio, Inc.: Raise no. 1, Feb 2023

Investors in this round

8 investors had bought by the notice of Feb 17, 2023: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $2 M still to sell
Smallest investment taken
$5,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce McCormick · Executive Officer, Director
  • Paul Laur · Executive Officer, Director
  • Dana Barnard · Director
  • Kevin McDonald · Director
  • Steve Buelow · Director
  • Steve Kiziuk · Director
  • Tuck Stibich · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Laur, Coo. Source: SEC Form D, newest notice filed Feb 17, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Mercury Bio, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2026).

    SEC Form D · Nov 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2026

That is all the official record says: Mercury Bio, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Mercury Bio, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 8 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Mercury Bio, Inc.
NameRoleNamed in
Bruce McCormickExecutive officerOct 2025
Paul LaurExecutive officerOct 2025
Bryan ScheerDirectorNov 2026
Alex KoglinDirectorOct 2025
Bruce McCormickDirectorOct 2025
Dana BarnardDirectorOct 2025
John TomesDirectorOct 2025
Kevin McDonaldDirectorOct 2025
Mike RiceDirectorOct 2025
Paul LaurDirectorOct 2025
Steve KiziukDirectorOct 2025
Steve BuelowDirectorFeb 2023
Tuck StibichDirectorFeb 2023